2024 SABCS Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Summaries & Highlights
2024 SABCS Annual Meeting Insights Hub
Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC for HER, too
FEATURING
Sara A. Hurvitz
- 467 views
- February 14, 2025
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Biology and Tumor Environment of Invasive Lobular Carcinoma - Brief Overview
FEATURING
Christos Sotiriou
- 181 views
- February 10, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: ASLAN Trial (KBCSG-28) and Ongoing Studies - Avoiding Axillary Surgery After Neoadjuvant Systemic Therapy in BC
FEATURING
Han-Byoel Lee
- 37 views
- February 7, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Advancing Breast Cancer Detection With Novel Imaging Technologies
FEATURING
Connie Lehman
- 115 views
- February 7, 2025
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Immunotherapy Strategies in ER+ Breast Cancer
FEATURING
Cesar Santa-Maria
- 241 views
- January 21, 2025
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Immunotherapy in eTNBC - Is It the End of the Beginning?
FEATURING
Giampaolo Bianchini
- 198 views
- January 17, 2025
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Next-Generation SERDs and Their Clinical Applications in ER+ Breast Cancer
FEATURING
Rinath Jeselsohn
- 204 views
- January 14, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Long-Term Outcomes of Immediate vs. Reduced Surgery in eBC - Meta-Analysis of 3 Randomised Trials Among 1,082 Women
FEATURING
Robert Hills
- 48 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Evolution of SERDs - Limitations of Fulvestrant and the Need for New Oral Therapies in ER+ Breast Cancer
FEATURING
Rinath Jeselsohn
- 60 views
- January 13, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, INSEMA, and OlympiA Trials in Breast Cancer Management
FEATURING
Margaret Gatti-Mays
- 1,516 views
- January 2, 2025
- 10
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx
FEATURING
Virginia Kaklamani
- 534 views
- January 2, 2025
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA
FEATURING
Sara Tolaney,
Hope Rugo
- 554 views
- December 22, 2024
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Precision Medicine in Breast Cancer
FEATURING
Laura van ’t Veer
- 485 views
- December 19, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer
FEATURING
Heather McArthur
- 190 views
- December 19, 2024
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3
FEATURING
Adam Brufsky
- 642 views
- December 18, 2024
- 8
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 299 views
- December 17, 2024
- 9
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 328 views
- December 17, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Suboptimal vs. Adequate Ovarian Suppression in Premenopausal Women With eBC - Insights From PREFER and GIM 23
FEATURING
Simone Nardin
- 244 views
- January 8, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Efficacy of Sacituzumab Govitecan in HR+/HER2- mBC and mTNBC - Clinical Data and Implications
FEATURING
Simone Nardin
- 345 views
- January 8, 2025
- 2
HR+
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Comparative OS of CDK4/6 Inhibitors + Aromatase Inhibitors in HR+/HER2- mBC - Insights From US Real-World Setting
FEATURING
Hope Rugo
- 177 views
- March 4, 2025
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Prescribing Patterns and Real-World Clinical Usage of Adjuvant Abemaciclib in High-Risk HR+ eBC
FEATURING
Sneha Rajendran
- 190 views
- January 27, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Immunotherapy Strategies in ER+ Breast Cancer
FEATURING
Cesar Santa-Maria
- 241 views
- January 21, 2025
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: CXCL11 in the Tumor Immune Microenvironment and Resistance to Endocrine Therapy in HR+ Breast Cancer
FEATURING
Fabiana Napolitano
- 13 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Efficacy of Sacituzumab Govitecan in HR+/HER2- mBC and mTNBC - Clinical Data and Implications
FEATURING
Simone Nardin
- 345 views
- January 8, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA Trial - Palbociclib Combined With Endocrine and HER2-Targeted Therapy in ER+/HER2+ mBC
FEATURING
Komal Jhaveri
- 29 views
- January 8, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EMBER-3 Trial - Imlunestrant Monotherapy and Combined With Abemaciclib in ER+/HER2- aBC
FEATURING
Komal Jhaveri
- 272 views
- January 8, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy in HR+/HER2- eBC - Insights From the NATALEE Trial
FEATURING
Erika Hamilton
- 501 views
- January 7, 2025
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Neoadjuvant Niraparib and Dostarlimab in BRCA-Mutated HR+/HER2- eBC - Results From TBCRC 056
FEATURING
Erica Mayer
- 36 views
- January 5, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EUROPA Trial - HRQoL With Radiotherapy vs. Endocrine Therapy in Luminal-Like eBC in Women Aged 70+
FEATURING
Icro Meattini
- 20 views
- January 5, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk Node-Negative HR+/HER2- eBC
FEATURING
Nan Chen
- 570 views
- January 2, 2025
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Association of HER2-Low Status With Progression-Free Survival in HR+/HER2- aBC Following CDK 4/6 Inhibitor Failure
FEATURING
José Antonio García Gordillo
- 182 views
- December 24, 2024
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Progesterone Receptor Expression and Recurrence Scores in HR+/HER2- eBC Regardless of Menopausal Status
FEATURING
Federica Martorana
- 274 views
- December 24, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 3,166 views
- December 22, 2024
- 10
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 753 views
- December 22, 2024
- 12
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PADMA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 411 views
- December 22, 2024
- 8
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Nab-Paclitaxel vs. Solvent-Based Paclitaxel in High-Risk eBC - Final Survival Results of WSG ADAPT HR+/HER2- Trial
FEATURING
Sherko Kuemmel
- 272 views
- December 20, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Oncotype DX Risk Stratification on Chemotherapy Use and Survival Outcomes in HR+ Node- eBC
FEATURING
Kai Johnson
- 316 views
- December 20, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Prediction of Chemotherapy Benefit by MammaPrint® in HR+/HER2- eBC - FLEX Registry Data
FEATURING
Adam Brufsky
- 216 views
- December 20, 2024
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: MammaPrint® and Predictive Pathways of CDK4/6 Inhibitor Resistance in ER+/HER2- eBC
FEATURING
Adam Brufsky
- 270 views
- December 20, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, and PI3K Pathway on Elacestrant Outcomes in HR+/HER2- Advanced Breast Cancer
FEATURING
Maxwell Lloyd
- 129 views
- December 17, 2024
- 2
HER2-Low
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Residual Disease After HER2 Inhibition - Role of ERBB2-Low Tumor Subpopulations and Their Transcriptional Programs
FEATURING
Sheheryar Kabraji
- 17 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Association of HER2-Low Status With Progression-Free Survival in HR+/HER2- aBC Following CDK 4/6 Inhibitor Failure
FEATURING
José Antonio García Gordillo
- 182 views
- December 24, 2024
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 3,166 views
- December 22, 2024
- 10
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Valemetostat + T-DXd in Previously Treated, Unresectable or Metastatic HER2-Low Breast Cancer
FEATURING
Sara Tolaney
- 11 views
- December 17, 2024
HER2+
2024 SABCS Annual Meeting Insights Hub
Beyond Proof of Concept: Evidence to Support Use of CDK4/6 in mBC for HER, too
FEATURING
Sara A. Hurvitz
- 467 views
- February 14, 2025
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Incidence and Risk Factors for Brain Metastases in HER2+ Primary Breast Cancer - A Retrospective Analysis
FEATURING
Anu Gaba
- 154 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Residual Disease After HER2 Inhibition - Role of ERBB2-Low Tumor Subpopulations and Their Transcriptional Programs
FEATURING
Sheheryar Kabraji
- 17 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA Trial - Palbociclib Combined With Endocrine and HER2-Targeted Therapy in ER+/HER2+ mBC
FEATURING
Komal Jhaveri
- 29 views
- January 8, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA Trial - CDK4/6 Inhibitors in Maintenance Therapy for HER2+ mBC
FEATURING
Erika Hamilton
- 52 views
- January 7, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: neoHIP Study of Neoadjuvant HER2-Targeted Therapy +/- IO With Pembrolizumab
FEATURING
Heather McArthur
- 67 views
- January 2, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 753 views
- December 22, 2024
- 12
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Effectiveness of Post-T-DXd Treatments in HER2+ mBC - EN-SEMBLE Study
FEATURING
Kazuki Nozawa
- 166 views
- December 20, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd
FEATURING
Sara Tolaney
- 30 views
- December 17, 2024
Triple-Negative Breast Cancer (TNBC)
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: cDNA Molecular Complete Response and pCR in Diverse Early TNBC Patients Receiving Neoadjuvant Chemo - Single-Arm Prospective Study
FEATURING
Gregory Vidal
- 7 views
- March 19, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: NSABP B-59/GBG-96-GeparDouze Phase 3 Trial - Neoadjuvant Chemo With Atezo/Placebo Followed by Adjuvant Atezo/Placebo for Stage 2 & 3 TNBC
FEATURING
Charles Geyer
- 145 views
- February 7, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: DNMT3A Protein Expression in TNBC
FEATURING
Roberto Leon-Ferre
- 18 views
- February 3, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Immunotherapy in eTNBC - Is It the End of the Beginning?
FEATURING
Giampaolo Bianchini
- 198 views
- January 17, 2025
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Phase 3, Randomized Study of Adjuvant Sacituzumab Tirumotecan + Pembro vs. TPC in Patients With TNBC Who Received Neoadjuvant Therapy & Did Not Achieve a PCR at Surgery
FEATURING
Heather McArthur
- 67 views
- January 2, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Efficacy of Sacituzumab Govitecan in HR+/HER2- mBC and mTNBC - Clinical Data and Implications
FEATURING
Simone Nardin
- 345 views
- January 8, 2025
- 2
Other Videos
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor-Infiltrating Lymphocyte Levels and MammaPrint® Recurrence Risk in eBC
FEATURING
Zoran Gatalica
- 22 views
- March 19, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor Intrinsic & Extrinsic Characteristics of Invasive Lobular Carcinomas
FEATURING
Christos Sotiriou
- 28 views
- February 10, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Biology and Tumor Environment of Invasive Lobular Carcinoma - Brief Overview
FEATURING
Christos Sotiriou
- 181 views
- February 10, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: E-Cadherin Inactivation Shapes Tumor Microenvironment Specificities in Invasive Lobular Carcinoma
FEATURING
Christos Sotiriou
- 16 views
- February 10, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: GeoMx DSP and CosMx Single-Cell Spatial Transcriptomics for Molecular Characterization of Invasive Lobular Breast Cancer Cells and Their Microenvironment
FEATURING
Christos Sotiriou
- 10 views
- February 10, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Spatial Transcriptomics-Derived Classification of Invasive Lobular Carcinoma: Associations With Clinical, Genomic Characteristics, and Prognosis
FEATURING
Christos Sotiriou
- 11 views
- February 10, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: ASLAN Trial (KBCSG-28) and Ongoing Studies - Avoiding Axillary Surgery After Neoadjuvant Systemic Therapy in BC
FEATURING
Han-Byoel Lee
- 37 views
- February 7, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Advancing Breast Cancer Detection With Novel Imaging Technologies
FEATURING
Connie Lehman
- 115 views
- February 7, 2025
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Risk-Reducing Surgeries and Survival in Young BRCA Carriers With Breast Cancer - International Cohort Results
FEATURING
Matteo Lambertini
- 116 views
- February 7, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor Intrinsic and Extrinsic Characteristics of Invasive Lobular Carcinomas
FEATURING
Lise Mangiante
- 14 views
- February 7, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: BWEL Trial - Impact of Weight Loss Intervention on Metabolic and Inflammatory Biomarkers in Obese Women With BC
FEATURING
Jennifer Ligibel
- 43 views
- February 7, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Somatic Structural Variation and Longitudinal ctDNA Analysis in eBC
FEATURING
Mitchell Elliott
- 46 views
- February 3, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Next-Generation SERDs and Their Clinical Applications in ER+ Breast Cancer
FEATURING
Rinath Jeselsohn
- 204 views
- January 14, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Validating the Association Between TILs, ER Status, and Radiotherapy Benefit in N+ Breast Cancer - DBCG Study
FEATURING
Demet Özcan
- 10 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Long-Term Outcomes of Immediate vs. Reduced Surgery in eBC - Meta-Analysis of 3 Randomised Trials Among 1,082 Women
FEATURING
Robert Hills
- 48 views
- January 13, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Evolution of SERDs - Limitations of Fulvestrant and the Need for New Oral Therapies in ER+ Breast Cancer
FEATURING
Rinath Jeselsohn
- 60 views
- January 13, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Early Outcomes of Monitoring vs Surgery (+/- Radiation and Endocrine Therapy) for Low-Risk DCIS - COMET Study (AFT-25)
FEATURING
Eun-Sil Hwang
- 32 views
- January 13, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Suboptimal vs. Adequate Ovarian Suppression in Premenopausal Women With eBC - Insights From PREFER and GIM 23
FEATURING
Simone Nardin
- 244 views
- January 8, 2025
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Anti-RANKL Bone Resorptive Therapy in Patients With Breast Cancer Treated With Pembrolizumab
FEATURING
Alexis LeVee
- 37 views
- January 5, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Overall Survival Results of BRIA-IMT Allogeneic Whole Cell-Based Vaccine in mBC
FEATURING
Saranya Chumsri
- 33 views
- January 5, 2025
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, INSEMA, and OlympiA Trials in Breast Cancer Management
FEATURING
Margaret Gatti-Mays
- 1,516 views
- January 2, 2025
- 10
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Key Trials Including EMBER-3 & TAILORx
FEATURING
Virginia Kaklamani
- 534 views
- January 2, 2025
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA
FEATURING
Sara Tolaney,
Hope Rugo
- 554 views
- December 22, 2024
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EMBER-3 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 561 views
- December 22, 2024
- 6
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Clinically Actionable Genomic Alterations and Prognostic Insights in Breast Cancer Brain Metastases
FEATURING
Gaia Griguolo
- 203 views
- December 20, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Lobular vs. Ductal Carcinoma Outcomes by Molecular Subtypes in Young Women With eBC Receiving Neoadjuvant Chemo
FEATURING
Jason Jincong Freeman
- 298 views
- December 20, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Precision Medicine in Breast Cancer
FEATURING
Laura van ’t Veer
- 485 views
- December 19, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer
FEATURING
Heather McArthur
- 190 views
- December 19, 2024
- 7
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Breast Cancer Polygenic Risk Score and Patient Survival Outcomes in Pathways Study
FEATURING
Arya Mariam Roy
- 64 views
- December 19, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3
FEATURING
Adam Brufsky
- 642 views
- December 18, 2024
- 8
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemo in Young Patients With eBC
FEATURING
Megan Tesch
- 82 views
- December 17, 2024
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 299 views
- December 17, 2024
- 9
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 328 views
- December 17, 2024
- 4